JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...

Former Vice President of India, Jagdeep Dhankhar, was admitted to the Cardiology Department of the All-India Institute of ...

A mobile phone application can characterize patterns of recovery from neurological manifestations of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC), with ...

DEAR DR. ROACH: I am an 82-year old man who was in good health until I found out that I have an issue in my left kidney. My ...

Sometimes, I feel like writing the same article four times could be considered a bit of a meme. But then I remember that this is a pretty phenomenal achievement for any streamer, let alone an AI ...

The DWP has issued a full list of 533 conditions which could qualify you for a £187 a week payment. Personal Independence Payments (PIP) are a benefit given out to people who need help with extra ...

Brain organoids are 3D tissues grown in cell culture from human pluripotent stem cells. Brain organoids are proving to be an exceptional tool for modeling brain development and neurological disease.

Our care team is dedicated to providing and improving care for patients recovering in the hospital from neurological trauma, disorders, and surgery. University of Utah Health's state-of-the-art Neuro ...

Five hundred people in a small Canadian province were diagnosed with a mystery brain disease. What would it mean for the patients if the disease was never real? In early 2019, officials at a hospital ...

Neurological diseases affect the nervous system, including the brain, spinal cord, and peripheral nerves that carry signals throughout your body. These conditions can disrupt movement, thinking, mood, ...

An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...